Development of a cancer vaccine strategy by tumor antigen targeting to CD169+ antigen presenting cells.

den Haan, J. (Speaker)

Activity: Talk or presentation › Oral presentation

Period23 May 2019
Event titleCIMT meeting: The Association for Cancer Immunotherapy
Event typeSeminar
LocationMainz, Germany
Degree of RecognitionInternational